论文部分内容阅读
目的探讨孟鲁司特与沙美特罗替卡松联合应用治疗支气管哮喘临床效果。方法选取2009年10月份-2011年6月份因支气管哮喘就诊于我院进行治疗的患者160例,随机分为治疗组(采用孟鲁司特与沙美特罗替卡松联合用药治疗)78例,对照组(仅采用沙美特罗替卡松治疗)82例,观察两组治疗前后临床症状改善情况级哮喘控制情况,并对两组结果进行统计学分析。结果治疗组临床症状治愈56例,显效17例,总有效率为93.6%,疗效明显优于对照组。治疗组在治疗后患者的哮喘控制情况明显好于对照组。结论孟鲁司特与沙美特罗替卡松联合应用治疗支气管哮喘具有较好的疗效,建议临床普遍应用。
Objective To investigate the clinical effect of montelukast combined with salmeterol and fluticasone in the treatment of bronchial asthma. Methods A total of 160 patients with bronchial asthma who were treated in our hospital from October 2009 to June 2011 were randomly divided into treatment group (treated with montelukast and salmeterol and fluticasone in combination) The control group (only salmeterol and ticarcasone treatment) 82 cases, the two groups before and after treatment to observe the situation to improve the level of asthma control, and the results of two groups were statistically analyzed. Results The clinical symptoms of the treatment group were cured 56 cases, markedly effective in 17 cases, the total effective rate was 93.6%, the effect was significantly better than the control group. The treatment group after treatment in patients with asthma control was significantly better than the control group. Conclusion Montelukast combined with salmeterol and fluticasone treatment of bronchial asthma has a good effect, it is recommended that the clinical application.